Skip to main content
NVDA0.00%AAPL-0.04%GOOGL-3.15%MSFT0.00%AMZN+0.10%TSM-4.52%SPCX-9.14%META-0.52%AVGO-4.31%TSLA-0.38%LLY+2.83%BRK-B+1.50%MU-1.05%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK-2.89%1398.HK-1.34%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-0.22%3988.HK-1.80%HD+4.33%CAT-4.89%0005.HK-1.23%PM+2.17%HSBA.L-2.45%0857.HK-0.82%GE-0.79%AP2d-6.79%1288.HK-0.30%0939.HK-0.61%AMAT-8.16%NVS+1.52%MS-1.63%DELL-6.78%PLNJPY-1.46%EURAUD-1.28%EURCAD-1.15%AUDUSD+1.06%EURJPY-0.96%USDCAD-0.91%USDTHB+0.86%SGDJPY-0.84%GBPZAR+0.78%USDJPY-0.77%USDZAR+0.77%EURNZD-0.75%EURGBP-0.75%CHFSEK+0.73%AUDCHF+0.64%USDPLN+0.64%EURCHF-0.62%EURZAR+0.58%NZDUSD+0.54%NOKJPY-0.54%GBPAUD-0.53%GBPUSD+0.53%AUDNZD+0.52%CADCHF+0.52%EURNOK-0.48%CHFSGD+0.46%EURPLN+0.45%AUDNOK-0.43%GBPCAD-0.42%GBPTRY+0.41%USDCHF-0.41%NZDCAD-0.39%CHFJPY-0.38%AUDJPY+0.33%NZDSGD-0.32%GBPHKD+0.32%EURHKD-0.31%USDNOK-0.30%GBPMXN-0.28%USDSEK+0.27%NZDJPY-0.24%GBPJPY-0.24%EURUSD-0.22%USDTRY+0.20%USDCNH-0.20%EURCNH-0.19%USDMXN+0.18%CADJPY+0.18%EURSGD-0.17%USDDKK+0.17%USDILS+0.16%NZDMXN-0.15%CHFNOK+0.15%USDHKD-0.15%AUDCAD+0.14%AUDSGD-0.13%NZDCHF+0.12%GBPCHF+0.11%EURSEK+0.10%EURCZK+0.05%AUDDKK+0.04%USDCOP-0.04%GBPNZD-0.03%GBPSGD+0.02%EURDKK-0.01%USDSGD0.00%GAGUSD-5.89%XAGUSD-5.89%XPTUSD-4.00%GAUUSD-2.84%XAUUSD-2.84%HG1-2.70%UKOIL+2.43%USOIL+1.35%SUGAR0.00%XNGUSD0.00%COFFEE0.00%COCOA0.00%BTCUSD-3.35%ETHUSD+16.36%USDTUSD-0.02%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.75%ZECUSDT-7.95%DOGEUSD+14.39%XMRUSDT-1.77%LINKUSD+14.52%XLMUSD-4.59%BCHUSDT-4.51%LTCUSD+8.69%UNIUSD-6.06%SUIUSD-5.62%HBARUSDT-6.18%TONUSD+26.39%TAOUSDT-5.75%AAVEUSD-5.52%DOTUSDT-3.05%ICPUSDT-6.22%WLDUSDT-7.21%ONDOUSDT-7.19%ARBUSDT-4.79%JUPUSDT-5.17%ATOMUSDT-3.26%INJUSDT-8.12%STXUSDT-11.12%TIAUSDT-6.23%FETUSDT-6.08%PYTHUSDT-7.51%SEIUSDT-9.27%IMXUSDT-7.91%GRTUSDT-6.54%OPUSDT-8.75%WIFUSDT-6.99%IOTAUSDT-5.48%AXSUSDT-5.93%POLUSDT-4.92%FARTCOINUSDT-5.87%EOSUSDT-2.04%DYDXUSDT-6.41%GALAUSDT-5.09%ORDIUSDT-3.33%RONINUSDT-5.30%NOTUSDT-4.94%NVDA0.00%AAPL-0.04%GOOGL-3.15%MSFT0.00%AMZN+0.10%TSM-4.52%SPCX-9.14%META-0.52%AVGO-4.31%TSLA-0.38%LLY+2.83%BRK-B+1.50%MU-1.05%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK-2.89%1398.HK-1.34%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-0.22%3988.HK-1.80%HD+4.33%CAT-4.89%0005.HK-1.23%PM+2.17%HSBA.L-2.45%0857.HK-0.82%GE-0.79%AP2d-6.79%1288.HK-0.30%0939.HK-0.61%AMAT-8.16%NVS+1.52%MS-1.63%DELL-6.78%PLNJPY-1.46%EURAUD-1.28%EURCAD-1.15%AUDUSD+1.06%EURJPY-0.96%USDCAD-0.91%USDTHB+0.86%SGDJPY-0.84%GBPZAR+0.78%USDJPY-0.77%USDZAR+0.77%EURNZD-0.75%EURGBP-0.75%CHFSEK+0.73%AUDCHF+0.64%USDPLN+0.64%EURCHF-0.62%EURZAR+0.58%NZDUSD+0.54%NOKJPY-0.54%GBPAUD-0.53%GBPUSD+0.53%AUDNZD+0.52%CADCHF+0.52%EURNOK-0.48%CHFSGD+0.46%EURPLN+0.45%AUDNOK-0.43%GBPCAD-0.42%GBPTRY+0.41%USDCHF-0.41%NZDCAD-0.39%CHFJPY-0.38%AUDJPY+0.33%NZDSGD-0.32%GBPHKD+0.32%EURHKD-0.31%USDNOK-0.30%GBPMXN-0.28%USDSEK+0.27%NZDJPY-0.24%GBPJPY-0.24%EURUSD-0.22%USDTRY+0.20%USDCNH-0.20%EURCNH-0.19%USDMXN+0.18%CADJPY+0.18%EURSGD-0.17%USDDKK+0.17%USDILS+0.16%NZDMXN-0.15%CHFNOK+0.15%USDHKD-0.15%AUDCAD+0.14%AUDSGD-0.13%NZDCHF+0.12%GBPCHF+0.11%EURSEK+0.10%EURCZK+0.05%AUDDKK+0.04%USDCOP-0.04%GBPNZD-0.03%GBPSGD+0.02%EURDKK-0.01%USDSGD0.00%GAGUSD-5.89%XAGUSD-5.89%XPTUSD-4.00%GAUUSD-2.84%XAUUSD-2.84%HG1-2.70%UKOIL+2.43%USOIL+1.35%SUGAR0.00%XNGUSD0.00%COFFEE0.00%COCOA0.00%BTCUSD-3.35%ETHUSD+16.36%USDTUSD-0.02%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.75%ZECUSDT-7.95%DOGEUSD+14.39%XMRUSDT-1.77%LINKUSD+14.52%XLMUSD-4.59%BCHUSDT-4.51%LTCUSD+8.69%UNIUSD-6.06%SUIUSD-5.62%HBARUSDT-6.18%TONUSD+26.39%TAOUSDT-5.75%AAVEUSD-5.52%DOTUSDT-3.05%ICPUSDT-6.22%WLDUSDT-7.21%ONDOUSDT-7.19%ARBUSDT-4.79%JUPUSDT-5.17%ATOMUSDT-3.26%INJUSDT-8.12%STXUSDT-11.12%TIAUSDT-6.23%FETUSDT-6.08%PYTHUSDT-7.51%SEIUSDT-9.27%IMXUSDT-7.91%GRTUSDT-6.54%OPUSDT-8.75%WIFUSDT-6.99%IOTAUSDT-5.48%AXSUSDT-5.93%POLUSDT-4.92%FARTCOINUSDT-5.87%EOSUSDT-2.04%DYDXUSDT-6.41%GALAUSDT-5.09%ORDIUSDT-3.33%RONINUSDT-5.30%NOTUSDT-4.94%
OR

Organogenesis Holdings Inc. (ORGO)

NASDAQ • Healthcare

$1.03
+$0.03 (+3.9%)
Market closed

Last close at October 22, 2026 at 20:00 UTC

Open$0.99
Day Range$0.99 - $1.05
Avg. Volume (3M)781.1K
Market Cap$133.1M
52 Week Range
$0.93$7.08
Next EarningsIn 14 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$43.7M100%
Gross Profitminus cost of goods$20M46%

Fundamentals & Financials

Revenue (TTM)
$456.5M
Net Income (TTM)
-$90.2M
EPS (TTM)
-$0.82
ROA (TTM)
-22.2%
Current Ratio
3.52
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+44.2%Q1 2026$0.31
-27.6%Q2 2026-$0.37
-102.9%Q3 2026-$0.71
Next

Nov 5

in 14 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -102.9%

Organogenesis’ revenue miss drove a steep year-over-year decline in the second fiscal quarter of 2026, based on preliminary results reported August 6, 2026. Revenue fell 56.6% to roughly $43.8 million, and on a consensus basis it trailed expectations, with revenue of $43.8 million versus the $54.3 million estimate (-19.4%), down from $100.8 million a year ago. Cash generation was also negative, with operating cash flow of roughly -$31.7 million for the quarter. Looking ahead, next-period consensus calls for EPS of -$0.18 on revenue of $52.1 million.

Next report — what to expect

Organogenesis Holdings Inc. (ORGO) reports on November 5, 2026. Wall Street is expecting EPS of -$0.177 on revenue of $52.1 million. For trailing context, revenue fell -56.6% year over year last quarter. ORGO has beaten EPS in 3 of 8 most recent quarters, so attention may focus on profitability versus consensus and revenue delivery.

View full earnings history

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc. develops regenerative medicine and bioactive products for wound care, surgical, and sports medicine settings in the healthcare field, and its shares trade on NASDAQ under ORGO. Across its U.S. business, revenue was $563.0 million in FY2025, with products sold into hospital, physician-office, surgical-center, wound-care, and government settings.

Name
Organogenesis Holdings Inc.
CEO
Gary S. Gillheeney
Website
organogenesis.com
Industry
Healthcare
Year Founded
1985
Employees
854

Today's Snapshot

AI-generated

The day ended with ORGO 3.9% higher at 1.03, in line with a firmer sector. ORGO reports earnings on 5 November.

Trading Volume

Below 10d avg (903.7K)

722.7K

vs S&P 500 Today

Strong Outperformance

+5.16%

Updated: October 22, 2026 at 20:18 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
ORGO shows a clear downside bias as price sits near $1.03 while short and medium moving averages remain well above current levels and the 200-day average is much higher, underscoring longer-term weakness. Trend strength is pronounced with a high ADX, and momentum measures are mixed but leaning negative—RSI is oversold while MACD and CCI signal deterioration. Volume-based flow is unfavorable as OBV remains elevated to the downside, and volatility is notable with an ATR around 8% of price. Technical takeaway: Strong Sell — trend strength and moving-average pressure confirm the bearish stance.
All signals
  • EMA (5 indicators)$1.10 - $2.60
    Sell
  • RSI (14)26.68
    Buy
  • Stochastic %K (14, 3, 3)17.84
    Buy
  • MACD Level (12, 26)-0.14
    Sell

Peers & Related Assets

VREXVarex Imaging Corporation
$18.41-0.1%
ESPREsperion Therapeutics, Inc.
$3.180.0%
ANGOAngioDynamics, Inc.
$12.02+1.1%
EOLSEvolus, Inc.
$7.41+0.1%
EBSEmergent BioSolutions Inc.
$6.23+0.5%
SIGASIGA Technologies, Inc.
$3.15+1.0%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.